Heron Patrick J (CIK 0001365617)

Latest company ownership

Shares held
5,219,440
Last filed at
Sep 30, 2025
Confidence Score
59.4
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
3,116,912
Last filed at
Jul 24, 2019
Confidence Score
50.2
2025Q4
Confidence Score History
2019Q3 2025Q4
Shares held
1,538,316
Last filed at
Jul 6, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
1,353,640
Last filed at
Oct 30, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
ANAB - ANAPTYSBIO, INC
Role: 10% Owner
Shares held
973,612
Last filed at
May 15, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
Shares held
540,498
Last filed at
May 14, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
PASG - Passage BIO, Inc.
Role: Director
Shares held
432,802
Last filed at
Mar 3, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
246,668
Last filed at
Apr 22, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
Shares held
214,281
Last filed at
Oct 20, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
PCVX - Vaxcyte, Inc.
Role: Director
Shares held
140,824
Last filed at
Jun 16, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
27,052
Last filed at
Jun 18, 2024
Confidence Score
51.2
2025Q4
Confidence Score History
2020Q1 2025Q4
HLVX - HilleVax, Inc.
Role: Director
Shares held
0
Last filed at
Sep 17, 2025
Confidence Score
43.4
2025Q4
Confidence Score History
2022Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 26, 2025 Sep 30, 2025 MBX Biosciences, Inc. Director Buy 100.0 +666,666 14.64% ✗ $12M
Sep 17, 2025 Sep 17, 2025 HilleVax, Inc. Director Sell 15.0 -8,552,536 -100.00% ✗ $16.7M
Jun 13, 2025 Jun 17, 2025 Arcutis Biotherapeutics, Inc. Director Buy 48.8 +2,646 0.03% ✗ $34.6K
Jun 4, 2025 Jun 6, 2025 Arcutis Biotherapeutics, Inc. Director Buy 48.8 +2,268 0.03% ✗ $30.2K
May 21, 2025 May 23, 2025 Arcutis Biotherapeutics, Inc. Director Buy 60.0 +5,040 0.06% ✗ $68.8K
May 15, 2025 May 19, 2025 Arcutis Biotherapeutics, Inc. Director Buy 48.8 +2,520 0.03% ✗ $34.3K
May 13, 2025 May 15, 2025 Arcutis Biotherapeutics, Inc. Director Buy 60.0 +8,674 0.10% ✗ $119.4K
May 9, 2025 May 13, 2025 Arcutis Biotherapeutics, Inc. Director Buy 60.0 +6,300 0.07% ✗ $85.7K
Mar 14, 2025 Mar 18, 2025 Mirum Pharmaceuticals, Inc. Director Buy 48.8 +549 0.01% ✗ $24.2K
Mar 10, 2025 Mar 12, 2025 Mirum Pharmaceuticals, Inc. Director Buy 60.0 +2,298 0.06% ✗ $99.5K
Mar 6, 2025 Mar 10, 2025 Mirum Pharmaceuticals, Inc. Director Buy 60.0 +1,915 0.05% ✗ $83.7K
Mar 4, 2025 Mar 6, 2025 Mirum Pharmaceuticals, Inc. Director Buy 52.5 +1,602 0.04% ✗ $72.7K
Sep 18, 2024 Sep 20, 2024 Mirum Pharmaceuticals, Inc. Director Buy 47.5 +115 0.00% ✗ $4.3K
Sep 16, 2024 Sep 17, 2024 MBX Biosciences, Inc. Director Buy 100.0 +625,000 15.91% ✗ $10M
Sep 6, 2024 Sep 10, 2024 Mirum Pharmaceuticals, Inc. Director Buy 47.5 +230 0.01% ✗ $9.6K
Apr 4, 2024 Apr 8, 2024 HilleVax, Inc. Director Buy 60.0 +8,850 0.10% ✗ $128.3K
Mar 4, 2024 Mar 6, 2024 Arcutis Biotherapeutics, Inc. Director Buy 65.0 +21,052 0.24% ✗ $200K
Nov 9, 2023 Nov 14, 2023 Mirum Pharmaceuticals, Inc. Director Buy 60.0 +2,910 0.08% ✗ $82.4K
Oct 24, 2023 Oct 26, 2023 Arcutis Biotherapeutics, Inc. Director Buy 72.5 +80,000 0.91% ✗ $200K
Sep 13, 2023 Sep 15, 2023 Mirum Pharmaceuticals, Inc. Director Buy 60.0 +2,625 0.07% ✗ $81.4K
Sep 11, 2023 Sep 13, 2023 Mirum Pharmaceuticals, Inc. Director Buy 67.5 +8,437 0.23% ✗ $256.8K
Aug 31, 2023 Sep 5, 2023 Mirum Pharmaceuticals, Inc. Director Buy 92.5 +147,991 4.15% ✗ $3.9M
Aug 5, 2022 Aug 9, 2022 Arcutis Biotherapeutics, Inc. Director Buy 93.8 +250,000 2.95% ✗ $5M
May 3, 2022 May 3, 2022 HilleVax, Inc. Director Buy 100.0 +1,764,706 26.06% ✗ $30M
Oct 20, 2020 Oct 20, 2020 Tarsus Pharmaceuticals, Inc. 10% Owner Buy 100.0 +312,500 19.47% ✗ $5M
Jun 16, 2020 Jun 16, 2020 Vaxcyte, Inc. Director Buy 100.0 +250,000 12.14% ✗ $4M
Mar 3, 2020 Mar 3, 2020 Passage BIO, Inc. Director Buy 100.0 +550,000 12.33% ✗ $9.9M
Feb 4, 2020 Feb 6, 2020 Arcutis Biotherapeutics, Inc. Director Buy 93.8 +500,000 4.98% ✗ $8.5M
Oct 29, 2019 Oct 30, 2019 Phathom Pharmaceuticals, Inc. 10% Owner Buy 100.0 +1,052,631 16.89% ✗ $20M
Jul 22, 2019 Jul 24, 2019 Mirum Pharmaceuticals, Inc. Director Buy 100.0 +450,000 14.44% ✗ $6.8M
May 30, 2018 May 30, 2018 Iterum Therapeutics plc Director Buy 100.0 +456,099 42.14% ✗ $5.9M
Jan 31, 2017 Jan 31, 2017 ANAPTYSBIO, INC 10% Owner Buy 100.0 +400,000 100.00% ✗ $6M
Jan 31, 2017 Jan 31, 2017 ANAPTYSBIO, INC 10% Owner Buy 100.0 +400,000 100.00% ✗ $6M
May 12, 2015 May 14, 2015 COLLEGIUM PHARMACEUTICAL, INC Director Buy 95.0 +150,000 8.63% ✗ $1.8M
Apr 20, 2015 Apr 22, 2015 Cidara Therapeutics, Inc. Director Buy 100.0 +200,000 100.00% ✗ $3.2M